Clinical Study
Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals
Table 1
Clinical characteristics of patients.
| | Characteristics | Control () | CAD () | | SAP () | NSTEACS () | STEMI () |
| | Age (years) | 56.7 ± 11.7 | 59.18 ± 11.1 | 0.178 | 62.4 ± 10.0 | 60.6 ± 9.9 | 54.1 ± 12.3 | | Male/female | 28/22 | 133/49 | 0.032 | 25/15 | 60/30 | 36/16 | | BMI | 23.6 ± 3.1 | 24.2 ± 3.5 | 0.328 | 23.8 ± 3.1 | 23.9 ± 3.5 | 24.9 ± 3.8 | | Risk factors | | | | | | | | Hypertension, (%) | 0 | 72 (40%) | — | 17 (43%) | 35 (39%) | 20 (39%) | | Diabetes, (%) | 7 (14%) | 24 (13%) | 0.882 | 2 (5%) | 13 (14%) | 9 (17%) | | Dyslipidemia, (%) | 0 | 29 (16%) | — | 7 (18%) | 16 (18%) | 6 (12%) | | Smoking, (%) | 12 (24%) | 119 (65%) | <0.001 | 18 (45%) | 61 (68%) | 40 (77%) | | Family history, (%) | 0 | 39 (21%) | — | 7 (18%) | 19 (21%) | 13 (25%) | | Medications | | | | | | | | Aspirin, (%) | 0 | 51 (28%) | | 15 (38%) | 24 (27%) | 12 (23%) | | Clopidogrel, (%) | 0 | 8 (4%) | — | 3 (8%) | 2 (2%) | 3 (6%) | | Beta-blockers, (%) | 0 | 51 (28%) | — | 17 (43%) | 24 (27%) | 10 (19%) | | ACEI, (%) | 0 | 53 (29%) | — | 10 (25%) | 28 (31%) | 15 (29%) | | ARB, (%) | 0 | 30 (16%) | — | 9 (23%) | 12 (13%) | 9 (17%) | | CCB, (%) | 0 | 45 (25%) | — | 13 (33%) | 20 (22%) | 12 (23%) | | Statins, (%) | 0 | 46 (25%) | — | 18 (45%) | 18 (20%) | 10 (19%) |
|
|
versus control, versus control, versus SAP, versus SAP, versus NSTEACS, versus NSTEACS.
|
